Recall events
/
Event 62664
Event summary
Timeline bucket July 25, 2012
Product types Drug
Classifications Class II
Statuses Terminated
Recalling firm wording Lloyd Inc. of Iowa
Dossier provenance
Source snapshots represented here
openFDA Drug Enforcement
Report-date coverage
June 20, 2012–July 08, 2026
Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.
How coverage and grouping work
Device root-cause evidence is not applicable to this event.
No grouped product has the official product type device; this is not an unavailable-enrichment finding.
Complete imported group
Every recalled product in this event
4 official enforcement rows
Product dates, classifications, firms, and source wording remain attached to their individual rows.
Opening this dossier never hides products that did not match a prior timeline filter.
drug · product 1 of 4
Thyro-Tab 0.050 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
D-100-2013
Recall number D-100-2013
Initiated July 25, 2012
Classification Class II
Status Terminated
Quantity 3,789,426/50-mcg. tablets
App-derived interpretation
Potency or specification failure
reason.potency_specification_failure · v1.0.0
Subpotent
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Subpotent; 9-month stability interval
Code information Lot HB23111 and HC23111
Distribution pattern Distribution was nationwide and to Puerto Rico. There was no foreign, military, or government distribution.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[8072]
FDA event record
· Exact recall-number query on openFDA
drug · product 2 of 4
Levothroid (levothyroxine sodium tablets, USP), 50 mcg., 100-count bottles, Rx only, NDC 0456-1321-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.
D-101-2013
Recall number D-101-2013
Initiated July 25, 2012
Classification Class II
Status Terminated
Quantity 37,441/100-tablet bottles
App-derived interpretation
Potency or specification failure
reason.potency_specification_failure · v1.0.0
Subpotent
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Subpotent; 9-month stability interval
Code information Lot 1093992 and 1094095, exp. date 9/2012
Distribution pattern Distribution was nationwide and to Puerto Rico. There was no foreign, military, or government distribution.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[7744]
FDA event record
· Exact recall-number query on openFDA
drug · product 3 of 4
Thyro-Tab 0.075 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA
D-102-2013
Recall number D-102-2013
Initiated July 25, 2012
Classification Class II
Status Terminated
Quantity 1,924,133/75-mcg. tablets
App-derived interpretation
Potency or specification failure
reason.potency_specification_failure · v1.0.0
Subpotent
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Subpotent; 9-month stability interval
Code information Lot HF23111
Distribution pattern Distribution was nationwide and to Puerto Rico. There was no foreign, military, or government distribution.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[5641]
FDA event record
· Exact recall-number query on openFDA
drug · product 4 of 4
Levothroid (levothyroxine sodium tablets, USP), 75 mcg., 100-count bottles, Rx only, NDC 0456-1322-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.
D-103-2013
Recall number D-103-2013
Initiated July 25, 2012
Classification Class II
Status Terminated
Quantity 16,548/100-tablet bottles
App-derived interpretation
Potency or specification failure
reason.potency_specification_failure · v1.0.0
Subpotent
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Subpotent; 9-month stability interval
Code information Lot 1094098, exp. date 9/2012
Distribution pattern Distribution was nationwide and to Puerto Rico. There was no foreign, military, or government distribution.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[5555]
FDA event record
· Exact recall-number query on openFDA
